Karin Hoppe‐Seyler

2.1k total citations
39 papers, 1.6k citations indexed

About

Karin Hoppe‐Seyler is a scholar working on Molecular Biology, Oncology and Cancer Research. According to data from OpenAlex, Karin Hoppe‐Seyler has authored 39 papers receiving a total of 1.6k indexed citations (citations by other indexed papers that have themselves been cited), including 27 papers in Molecular Biology, 12 papers in Oncology and 11 papers in Cancer Research. Recurrent topics in Karin Hoppe‐Seyler's work include Virus-based gene therapy research (10 papers), Cancer, Hypoxia, and Metabolism (8 papers) and Cervical Cancer and HPV Research (7 papers). Karin Hoppe‐Seyler is often cited by papers focused on Virus-based gene therapy research (10 papers), Cancer, Hypoxia, and Metabolism (8 papers) and Cervical Cancer and HPV Research (7 papers). Karin Hoppe‐Seyler collaborates with scholars based in Germany, France and United States. Karin Hoppe‐Seyler's co-authors include Felix Hoppe‐Seyler, Felicitas Bossler, Anja Honegger, Julia Bulkescher, Claudia Lohrey, Holger Sültmann, Martin Scheffner, Nina Wagener, Daniela Schilling and Jasmin Sponagel and has published in prestigious journals such as Proceedings of the National Academy of Sciences, PLoS ONE and Hepatology.

In The Last Decade

Karin Hoppe‐Seyler

38 papers receiving 1.6k citations

Peers

Countries citing papers authored by Karin Hoppe‐Seyler

Since Specialization

Citations

This map shows the geographic impact of Karin Hoppe‐Seyler's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Karin Hoppe‐Seyler with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Karin Hoppe‐Seyler more than expected).

Fields of papers citing papers by Karin Hoppe‐Seyler

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Karin Hoppe‐Seyler. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Karin Hoppe‐Seyler. The network helps show where Karin Hoppe‐Seyler may publish in the future.

Co-authorship network of co-authors of Karin Hoppe‐Seyler

This figure shows the co-authorship network connecting the top 25 collaborators of Karin Hoppe‐Seyler. A scholar is included among the top collaborators of Karin Hoppe‐Seyler based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Karin Hoppe‐Seyler. Karin Hoppe‐Seyler is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Hypoxic HPV‐Positive Cancer Cells Are Particularly Sensitive to the Pro‐Senescent Effects of B‐MYB Repression Due to the Lack of Compensatory A‐MYB Induction 2025 ·Journal of Medical Virology ·Milica Velimirović, (unknown), Claudia Lohrey, Julia Bulkescher, Felix Hoppe‐Seyler, Karin Hoppe‐Seyler	1
2	Development of an Orthotopic HPV16-Dependent Base of Tongue Tumor Model in MHC-Humanized Mice 2023 ·Pathogens ·(unknown), (unknown), (unknown), (unknown), (unknown), (unknown), Matthias Bozza, Karin Hoppe‐Seyler, Mathias Heikenwälder, Richard P. Harbottle, Carine Michiels, Angelika B. Riemer	0
3	Revisiting the role of endogenous STAT3 in HPV‐positive cervical cancer cells 2023 ·Journal of Medical Virology ·(unknown), Maria Weber, (unknown), Angela Holzer, Karin Hoppe‐Seyler, Felix Hoppe‐Seyler	5
4	The impact of cycling hypoxia on the phenotype of HPV‐positive cervical cancer cells 2023 ·Journal of Medical Virology ·(unknown), (unknown), (unknown), Claudia Lohrey, Jeroen Krijgsveld, Karin Hoppe‐Seyler, Felix Hoppe‐Seyler	2
5	Dickkopf‐1 expression is repressed by oncogenic human papillomaviruses (HPVs) and regulates the Cisplatin sensitivity of HPV‐positive cancer cells in a JNK‐dependent manner 2022 ·International Journal of Cancer ·(unknown), Angela Holzer, Karin Hoppe‐Seyler, Felix Hoppe‐Seyler	8
6	Effects of Metformin on the virus/host cell crosstalk in human papillomavirus‐positive cancer cells 2021 ·International Journal of Cancer ·Karin Hoppe‐Seyler, (unknown), (unknown), (unknown), (unknown), Claudia Lohrey, Julia Bulkescher, Jeroen Krijgsveld, Felix Hoppe‐Seyler	22
7	Effects of the antifungal agent ciclopirox in HPV‐positive cancer cells: Repression of viral E6/E7 oncogene expression and induction of senescence and apoptosis 2019 ·International Journal of Cancer ·(unknown), (unknown), (unknown), (unknown), Julia Bulkescher, Martin Scheffner, Bruno Galy, Karin Hoppe‐Seyler, Felix Hoppe‐Seyler	30
8	Induction of dormancy in hypoxic human papillomavirus-positive cancer cells 2017 ·Proceedings of the National Academy of Sciences ·Karin Hoppe‐Seyler, Felicitas Bossler, Claudia Lohrey, Julia Bulkescher, Frank Rösl, Lars Jansen, Arnulf Mayer, Peter Vaupel, Matthias Dürst, Felix Hoppe‐Seyler	56
9	Dependence of Intracellular and Exosomal microRNAs on Viral E6/E7 Oncogene Expression in HPV-positive Tumor Cells 2015 ·PLoS Pathogens ·Anja Honegger, Daniela Schilling, (unknown), Jasmin Sponagel, Vladimir Kuryshev, Holger Sültmann, Martin Scheffner, Karin Hoppe‐Seyler, Felix Hoppe‐Seyler	201
10	The E6AP Binding Pocket of the HPV16 E6 Oncoprotein Provides a Docking Site for a Small Inhibitory Peptide Unrelated to E6AP, Indicating Druggability of E6 2014 ·PLoS ONE ·Katia Zanier, (unknown), (unknown), Eileen Reinz, Peter Sehr, Julia Bulkescher, Karin Hoppe‐Seyler, Gilles Travé, Felix Hoppe‐Seyler	41
11	Oncogenic Human Papillomaviruses Activate the Tumor-Associated Lens Epithelial-Derived Growth Factor (LEDGF) Gene 2014 ·PLoS Pathogens ·(unknown), Miriam Reuschenbach, Claudia Lohrey, Anja Honegger, Rosita Accardi, Massimo Tommasino, Manuel Llano, Magnus von Knebel Doeberitz, Karin Hoppe‐Seyler, Felix Hoppe‐Seyler	33
12	Endogenous BTG2 expression stimulates migration of bladder cancer cells and correlates with poor clinical prognosis for bladder cancer patients 2013 ·British Journal of Cancer ·Nina Wagener, Julia Bulkescher, Stephan Macher‐Goeppinger, Irini Karapanagiotou‐Schenkel, Gencay Hatiboglu, Mona Abdel Rahim, (unknown), (unknown), Patrick J. Bastian, Stefan C. Müller, Axel Haferkamp, Markus Hohenfellner, Felix Hoppe‐Seyler, Karin Hoppe‐Seyler	32
13	EZH2 Depletion Blocks the Proliferation of Colon Cancer Cells 2011 ·PLoS ONE ·(unknown), Nina Wagener, Stephan Macher‐Goeppinger, Axel Benner, Maria Fälth, Holger Sültmann, Angela Holzer, Karin Hoppe‐Seyler, Felix Hoppe‐Seyler	77
14	Development of peptide aptamer microarrays for detection of HPV16 oncoproteins in cell extracts 2010 ·Analytical Biochemistry ·Sophie Laurenson, Mark R. Pett, Karin Hoppe‐Seyler, Claudia Denk, Felix Hoppe‐Seyler, Nick Coleman, Paul Ko Ferrigno	17
15	Transtactin: a universal transmembrane delivery system forStrep‐tag II‐fused cargos 2009 ·Journal of Cellular and Molecular Medicine ·(unknown), Julia Bulkescher, Jennifer Reed, Martina Schnölzer, Hans Heid, Karin Hoppe‐Seyler, Felix Hoppe‐Seyler	5
16	Oncogenic human papillomaviruses block expression of the B‐cell translocation gene‐2 tumor suppressor gene 2009 ·International Journal of Cancer ·(unknown), Karin Hoppe‐Seyler, (unknown), Claudia Lohrey, Martin Scheffner, Matthias Dürst, Felix Hoppe‐Seyler	5
17	The enhancer of zeste homolog 2 gene contributes to cell proliferation and apoptosis resistance in renal cell carcinoma cells 2008 ·International Journal of Cancer ·Nina Wagener, (unknown), Julia Bulkescher, Irena Crnković‐Mertens, Karin Hoppe‐Seyler, Hanswalter Zentgraf, Maria Pritsch, Stephan Buse, Jesco Pfitzenmaier, Axel Haferkamp, Markus Hohenfellner, Felix Hoppe‐Seyler	59
18	A novel peptide motif binding to and blocking the intracellular activity of the human papillomavirus E6 oncoprotein 2008 ·Journal of Molecular Medicine ·(unknown), Martin Scheffner, (unknown), Peter Sehr, Claudia Lohrey, Felix Hoppe‐Seyler, Karin Hoppe‐Seyler	29
19	High nuclear Livin expression is a favourable prognostic indicator in renal cell carcinoma 2008 ·British Journal of Urology ·Axel Haferkamp, Jens Bedke, (unknown), Maria Pritsch, Nina Wagener, Stephan Buse, Irena Crnković‐Mertens, Karin Hoppe‐Seyler, Stephan Macher‐Goeppinger, Felix Hoppe‐Seyler, Frank Autschbach, Markus Hohenfellner	13
20	Expression of inhibitor of apoptosis protein Livin in renal cell carcinoma and non-tumorous adult kidney 2007 ·British Journal of Cancer ·Nina Wagener, Irena Crnković‐Mertens, (unknown), Stephan Macher-Göppinger, Jens Bedke, Elisabeth Gröne, (unknown), Maria Pritsch, Karin Hoppe‐Seyler, Stephan Buse, Axel Haferkamp, Frank Autschbach, Markus Hohenfellner, Felix Hoppe‐Seyler	29

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact